Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

AIM OF THE STUDY: Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The aim of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Juuti, Anne, Nordling, Stig, Fermér, Christian, Nilsson, Olle, Seppänen, Hanna, Haglund, Caj
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459962/
https://ncbi.nlm.nih.gov/pubmed/26053486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0129012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados